PRA CONTINUES THE TRANSFORMATION OF CLINICAL TRIALS WITH PREDICTIVV(TM)

RALEIGH, N.C, June 16 (Bernama-GLOBE NEWSWIRE) -- PRA Health Sciences (Nasdaq:PRAH), a leading global contract research organization, today announced its new Predictivv™ platform, the beginning of an entirely new approach on the role technology will play in the future of clinical development. The Predictivv™ platform will be a fully integrated solution for designing, planning and optimizing the management of global clinical studies. Designed around a unified platform that harmonizes data, processes, and people across every aspect of a clinical study, Predictivv™ will enable unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process. http://mrem.bernama.com/viewsm.php?idm=24683